Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?

To: rutz who wrote (1553)	7/30/1998 4:41:00 PM
From: Andrew Abraham	Read Replies (2) \| Respond to of 4122

Do you or any other IMDS investor know anything about IMDS' IRB board? The review board is composed of of Drs. from "Omega Gynecological and Obstetrics Group," and the "All-American Women's Diagnostic." Curiously, IMDS does not give any location for these doctors or their groups. I never heard of these groups and found nothing for them using Alta Vista. None of these Drs. appear to have an academic affiliation. Not having any physicians on its IRB with academic affiliations does not bode well. A breast surgeon and a neurologist are also listed as members of the review board. But neither affiliation or location is provided for either. Anybody know anything about these doctors?

To: rutz who wrote (1553)	7/30/1998 10:11:00 PM
From: KAKALAK	Read Replies (1) \| Respond to of 4122

Well said, Rutz Have you any answers to message # 1552?

To: rutz who wrote (1553)	7/30/1998 10:30:00 PM
From: Dan O	Read Replies (1) \| Respond to of 4122

Your defense of Linda and Deb are not logical. Obviously they would be better off if the product was approved since they have GIVEN THEMSELVES so damn many shares of MY company. The concern here is that they do well REGARDLESS of whether its approved because of the salaries, patent fees, shares etc. they gave to themselves. Their interests are no longer aligned with the shareholders. Further, if they have evidence of product failure, they would have the incentive (whether or not they would act on it) to continue the charade as if the product had a chance. They would have the incentive to keep issuing shares to new generations of suckers, give themselves more stock that they could cash out of, give themselves more "orally" agreed to patent fees, and so on at the expense of shareholders who might never see a product come to market.